Drugmaker Regeneron Pharmaceuticals is acquiring majority assets of bankrupt genetic testing firm 23andMe Holding for $256 million. The once-sizzling DNA-testing startup filed for bankruptcy in March, ...
Spokeo reports that DNA testing is transforming family discovery, with 25% of Americans finding unknown relatives, leading to ...